Life science executives are invited to attend the 2nd Real World Evidence and Market Access Symposium being held as a virtual event on April 11-12, 2022. The event is hosted by DGE, a leading global event management company that caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, health care, medical devices, and allied industries.
The event centers around discussions, keynotes and sessions about the latest advances and best practices for harnessing real-world data insights that are productive for patients, payers and providers.
Organizations can strengthen their business and reimbursement strategies by identifying and accessing the correct data, as well as understanding how to leverage secondary data for greater efficiency in clinical trials. The first step involves identifying the relevant data that will eventually pave the path for providing the right kind of treatment to the patients. This high-quality data will prove pivotal in determining which line of treatment is approved, reimbursed and prescribed.
The forum will feature reputed dignitaries with excellent knowledge of RWE and how it can be used across a spectrum of clinical development, regulatory approval and access. The panelists will also share insights into how to ensure greater transparency in designing protocols, collect the right kind of data, and ensure its usefulness while addressing patient needs.
Some important topics to discuss include:
- Improve scientific communication and build value maps for specific patient demographics
- Collaborating data while working with electronic health records, medical claims and patient registries
- Learn how RWE is being utilized in oncology plus RWD and expanded access programs
- Hear from the experts about what to do and what not to do working with FDA
- Leverage the insights learned from RWD to make trials more inclusive and diverse
- Access the evolving RWE for COVID 19 treatments to inform critical decision making
The 2nd Real World Evidence and Market Access Symposium will witness stalwarts across a spectrum of fields including data analytics, regulatory affairs, world data, evidence platforms/solutions, trial management software, data management software, digital platform technology, CROs, artificial intelligence, and machine learning. Join this symposium to learn how to overcome the challenges faced in using RWE to complement and innovate clinical trials.
To learn more, please visit https://nnw.fm/Mcw2q.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
No comments:
Post a Comment